10X Genomics Inc
NASDAQ:TXG

Watchlist Manager
10X Genomics Inc Logo
10X Genomics Inc
NASDAQ:TXG
Watchlist
Price: 16.69 USD 1.15% Market Closed
Market Cap: 2.1B USD

Wall Street
Price Targets

TXG Price Targets Summary
10X Genomics Inc

Wall Street analysts forecast TXG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TXG is 17.54 USD with a low forecast of 14.14 USD and a high forecast of 23.1 USD.

Lowest
Price Target
14.14 USD
15% Downside
Average
Price Target
17.54 USD
5% Upside
Highest
Price Target
23.1 USD
38% Upside
10X Genomics Inc Competitors:
Price Targets
DHR
Danaher Corp
14% Upside
RGEN
Repligen Corp
17% Upside
603127
Joinn Laboratories China Co Ltd
28% Downside
TEM
Tempus AI Inc
44% Upside
ADPT
Adaptive Biotechnologies Corp
21% Upside
VIMTALABS
Vimta Labs Ltd
22% Upside
1521
Frontage Holdings Corp
22% Upside
ONT
Oxford Nanopore Technologies PLC
64% Upside

Revenue
Forecast

Revenue Estimate
10X Genomics Inc

For the last 6 years the compound annual growth rate for 10X Genomics Inc's revenue is 27%. The projected CAGR for the next 4 years is 4%.

27%
Past Growth
4%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
10X Genomics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
10X Genomics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TXG's stock price target?
Price Target
17.54 USD

According to Wall Street analysts, the average 1-year price target for TXG is 17.54 USD with a low forecast of 14.14 USD and a high forecast of 23.1 USD.

What is 10X Genomics Inc's Revenue forecast?
Projected CAGR
4%

For the last 6 years the compound annual growth rate for 10X Genomics Inc's revenue is 27%. The projected CAGR for the next 4 years is 4%.

Back to Top